Antitumor Drug
ChemicalBook > CAS DataBase List > Lenalidomide

Lenalidomide

Antitumor Drug
Product Name
Lenalidomide
CAS No.
191732-72-6
Chemical Name
Lenalidomide
Synonyms
enaL;idomide;CC-5013;Revlimi;Revlimid;Lenalidomid;enalidomide;Lenadoamide;lenalidomide;To the amine
CBNumber
CB3855432
Molecular Formula
C13H13N3O3
Formula Weight
259.26
MOL File
191732-72-6.mol
More
Less

Lenalidomide Property

Melting point:
265-268 °C
Boiling point:
614.0±55.0 °C(Predicted)
Density 
1.460±0.06 g/cm3(Predicted)
storage temp. 
2-8°C
pka
10.75±0.40(Predicted)
CAS DataBase Reference
191732-72-6(CAS DataBase Reference)
More
Less

Safety

Risk Statements 
20/21/22
Safety Statements 
36/37
HazardClass 
IRRITANT
HS Code 
29339900
Hazardous Substances Data
191732-72-6(Hazardous Substances Data)
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Cayman Chemical
Product number
14643
Product name
Lenalidomide
Purity
≥98%
Packaging
100mg
Price
$125
Updated
2021/12/16
Cayman Chemical
Product number
14643
Product name
Lenalidomide
Purity
≥98%
Packaging
1g
Price
$313
Updated
2021/12/16
Cayman Chemical
Product number
14643
Product name
Lenalidomide
Purity
≥98%
Packaging
500mg
Price
$188
Updated
2021/03/22
Tocris
Product number
6305
Product name
Lenalidomide
Purity
≥98%(HPLC)
Packaging
100
Price
$49
Updated
2021/12/16
TRC
Product number
L328000
Product name
Lenalidomide
Packaging
5mg
Price
$85
Updated
2021/12/16
More
Less

Lenalidomide Chemical Properties,Usage,Production

Antitumor Drug

Lenalidomide is a kind of antitumor drugs that developed by American biological pharmaceutical companies. Its chemical structure is similar with thalidomide. It has many functions such as anti-tumor, immune regulation and anti-angiogenesis. It can inhibit the secretion of inflammatory cytokines, and increase the secretion of peripheral blood mononuclear anti-inflammatory cytokines. Vitro tests show that lenalidomide can inhibit the hyperplasia of some cell lines such as namalwa cell. It can inhibit the growth of patients’ multiple myeloma cells and MM1S cell. In addition, lenalidomide also can inhibit the expression of oxidase-2 (COX-2), but it has no effect on COX-1. Two multicenter randomized double-blind placebo-controlled clinical studies evaluate the safety and curative effect of lenalidomide that is used for multiple myeloma. The primary efficacy end point of the studies is time to progression (TTP). The interim analysis shows that TTP of the combination group is significantly superior to dexamethasone group. Recent clinical research results show that lenalidomide not only has curative effect on treating MDS and MM, but also on treating myeloma, leukemia, metastatic renal cell carcinoma, solid tumor, idiopathic generalized amyloidosis and systemic bone marrow fibrosis disease with marrow unripe.
Lenalidomide is a new derivative of thalidomide. But its teratogenic toxicity has not found. Its effectiveness is 100 times stronger than thalidomide. According to the result of three clinical trials, lenalidomide is the most effective drug in the treatment of multiple myeloma. More than half of patients can prolong survival time to more than 3 years after taking the drug. In addition, it is also the only effective drugs to treat myelodysplastic syndrome (MDS). Clinical results find that 64% of the patients with MDS need not use blood transfusion after treated by lenalidomide.
In December 2005, the US Food and Drug Administration (FDA) approved lenalidomide to be used in the treatment of myelodysplastic syndrome (MDS).
In March 2006, the FDA approved lenalidomide that was produced by American Celgene Biological Pharmaceutical Companies to be used in the treatment of multiple myeloma (MM).
On September 23, 2011, the European Medicines Agency (EMA) released information that they have confirmed that the benefits of lenalidomide(trade name: Revlimid) to be used in the treatment of patients group that was approved outweighed the risks. Meanwhile they warned the doctor the risk of the drug to cause new cancer cases. Lenalidomide has been used with dexamethasone to treat adult patients with multiple myeloma that has received at least one treatment. Three new studies show that the incidence of new cancer will be increased in the patients with newly diagnosed multiple myeloma treated by lenalidomide and other combined treatment increased incidence of cancer.
The above information is edited by the Chemicalbook Geqian.

Description

Lenalidomide is a derivative of thalidomide differing in the presence of an amino moiety in the 4-position and removal of one of the carbonyls of the phthaloyl ring. This derivative evolved from a structural-based effort to eliminate the adverse effects (somnolence, neuropathy, and teratogenicity) of thalidomide while maintaining or enhancing the appealing attributes. While the mechanism of action remains to be fully identified, lenalidomide inhibits TNF-a production in stimulated monocytes. In addition to inhibiting TNF-a secretion, the production of other pro-inflammatory cytokines is blocked. Complimentary to inhibition of pro-inflammatory cytokines, lenalidomide also increases the secretion of antiinflammatory cytokines, such as IL-10. Furthermore, lenalidomide inhibits secretion of angiogenic cytokines, VEGF and bFGF. Due to its immunomodulatory and antiangiogenic properties, lenalidomide has the potential for a wide spectrum of therapeutic applications. While other indications are under evaluation, lenalidomide has initially been launched for the treatment of myelodysplastic syndromes (MDS), a set of hematologic disorders that affect the bone marrow and result in a deficiency of mature blood cells. There are various types of MDS, and lenalidomide is approved for the type associated with a truncation of chromosome 5 known as deletion 5q MDS. In combination with dexamethasone, it has also been designated for the second-line treatment of multiple myeloma, a B cell malignancy characterized by excess monotypic plasma cells in the bone marrow. .

Chemical Properties

Yellow Solid

Originator

Celgene (US)

Uses

Immunomodulatory drug; analog of Thalidomide.

Uses

Lenalidomide (Revlimid, CC-5013) is a TNF-α secretion inhibitor with IC50 of 13 nM.

Uses

Lovastatin content <1% 98%

Uses

A Thalidomide analog known to have immunomodulatory properties

Definition

ChEBI: A dicarboximide that consists of 1-oxoisoindoline bearing an amino substituent at position 4 and a 2,6-dioxopiperidin-3-yl group at position 2. Inhibits the secretion of TNF-alpha.

brand name

Revlimid(Celgene).

Biochem/physiol Actions

Lenalidomide, a derivative of thalidomide, is an immunomodulatory agent that is approved drug for treatment of multiple myeloma. Apparently Lenalidomide is a ligand of ubiquitin E3 ligase cereblon that induces the enzyme to degrade the Ikaros transcription factors IKAROS family zinc finger 1 (IKZF1) and IKZF3. Lenalidomide possess pleiotropic antitumor effects. It is used in the treatment of 5q-deletion associated myelodysplastic syndrome (del(5q)-MDS).

Lenalidomide Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Lenalidomide Suppliers

Taizhou Creating Chemical Co., Ltd
Tel
576-88827176
Fax
86- 576 88822496
Email
sonya@creatingchem.com
Country
China
ProdList
129
Advantage
64
Jinan Kaypharm Chemical Co.,Ltd.
Tel
0531-86986780
Fax
0531-86986781
Email
sales@kaypharm.cn;
Country
China
ProdList
119
Advantage
55
Nanjing Wedo Pharm Tech Co., Ltd.
Tel
Email
190644657@qq.com
Country
China
ProdList
224
Advantage
58
Shanghai Bocimed Pharmaceutical Co.,Ltd.
Tel
Email
rui.fang@bocimed.com
Country
China
ProdList
167
Advantage
58
Nanjing Ze Feng biological medicine technology Co., Ltd.
Tel
Email
1670471576@qq.com
Country
China
ProdList
967
Advantage
58
shandong XuanHong Pharmaceutical Technology Co.,Ltd
Tel
0531-88801869
Fax
0531-88801867
Email
sciencechem@163.com
Country
China
ProdList
569
Advantage
55
Jinan Yuantai Pharmaceutical Co.,Ltd
Tel
0531-69959492
Fax
0531-88603458
Email
42660257@qq.com
Country
China
ProdList
216
Advantage
58
Shanghai Boyle Chemical Co., Ltd.
Fax
86-21-57758967
Email
sales@boylechem.com
Country
China
ProdList
2926
Advantage
55
J & K SCIENTIFIC LTD.
Tel
010-82848833- ;010-82848833
Fax
86-10-82849933
Email
jkinfo@jkchemical.com;market6@jkchemical.com
Country
China
ProdList
96815
Advantage
76
Chembest Research Laboratories Limited
Tel
021-20908456
Fax
021-58180499
Email
sales@BioChemBest.com
Country
China
ProdList
5947
Advantage
61
BeiJing Hwrk Chemicals Limted
Tel
0757-86329057- ;021-51691807
Fax
0757-86311057
Email
sales.gd@hwrkchemical.com;peter.shi@hwrkchemical.com
Country
China
ProdList
17295
Advantage
55
Energy Chemical
Tel
021-58432009
Fax
021-58436166
Email
sales8178@energy-chemical.com
Country
China
ProdList
43432
Advantage
61
Capot Chemical Co., Ltd
Tel
+86 (0) 571 85 58 67 18
Fax
0086-571-85864795
Email
sales@capotchem.com
Country
China
ProdList
18227
Advantage
66
Jia Xing Isenchem Co.,Ltd
Tel
0573-85285100
Fax
0573-85285100
Email
isenchem@163.com
Country
China
ProdList
9636
Advantage
66
Accela ChemBio Co.,Ltd.
Tel
400-0665055
Fax
021-50795055
Email
sales@accelachem.com
Country
China
ProdList
12010
Advantage
64
Nanjing Chemlin Chemical Co., Ltd
Tel
Fax
+86-25-83453306
Email
info@chemlin.com.cn
Country
China
ProdList
20007
Advantage
64
Shanghai Hanhong Scientific Co.,Ltd.
Tel
;021-54306202- ;
Fax
13764082696
Email
jerry.ma@hanhonggroup.com;jerry.ma@hanhonggroup.com;jerry.ma@hanhonggroup.com
Country
China
ProdList
43059
Advantage
64
Chemsky(shanghai)International Co.,Ltd.
Tel
021-50135380
Email
shchemsky@sina.com
Country
China
ProdList
32358
Advantage
50
XiaoGan ShenYuan ChemPharm co,ltd
Tel
0712-2580635- ;0712-2580635
Email
1791901229@qq.com;1791901229@qq.com;
Country
China
ProdList
8924
Advantage
52
Jinan Trio PharmaTech Co., Ltd.
Tel
+86 (531) 88811783;
Fax
+86 (531) 55696010 QQ 1762738062
Email
sales@trio-pharmatech.com (International market);trio@trio-pharmatech.com(Domestic market)
Country
China
ProdList
1856
Advantage
62
Wuhan Sunrise Technology Development Co., Ltd.
Tel
027-83314682
Fax
+86 (27) 8331-4682
Email
whsrtech@vip.163.com;whsrtech@vip.163.com
Country
China
ProdList
295
Advantage
62
China Langchem Inc.
Tel
021-58956006- ;021-58950017
Fax
021-58956100
Email
sales@langchem.com;sales3@langchem.com
Country
China
ProdList
416
Advantage
57
Tianjin heowns Biochemical Technology Co., Ltd.
Tel
400 638 7771
Email
sales@heowns.com
Country
China
ProdList
14457
Advantage
57
Shanghai Sunway Pharmaceutical Technology Co., Ltd
Tel
Fax
021 51613951
Email
vivian.zhu@3wpharm.com
Country
China
ProdList
9879
Advantage
57
Wuhan Fortuna Chemical Co., Ltd
Tel
027-59207852
Fax
QQ3130921841
Email
buy@fortunachem.com
Country
China
ProdList
2984
Advantage
58
Dalian Meilun Biotech Co., Ltd.
Tel
0411-62910999- ;0411-62910999
Email
sales@meilune.com;sales@meilune.com
Country
China
ProdList
3754
Advantage
58
BioBioPha Co., Ltd.
Tel
0871-65217109
Fax
0871-65215563
Email
sales@mail.biobiopha.com
Country
China
ProdList
5688
Advantage
65
ShangHai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847
Fax
021-55068248
Email
3008007399@qq.com
Country
China
ProdList
4995
Advantage
60
S.Z. PhyStandard Bio-Tech. Co., Ltd.
Tel
;
Fax
0755 28094224
Email
3001280422@qq.com;marketing@phystandard.com
Country
China
ProdList
4840
Advantage
50
S.Z. PhyStandard Bio-Tech. Co., Ltd.
Tel
17727448752;0755-83725681-603
Fax
+86 755 28094224
Country
China
ProdList
4508
Advantage
50
Shanghai civi chemical technology co.,Ltd
Tel
86-21-34053660;34053661
Fax
86-21-34053661
Email
sale@labgogo.com
Country
China
ProdList
9886
Advantage
52
Suzhou Sibian Chemical Technology Co.,Ltd.
Tel
0512-65617459 18915409046
Fax
0512-65617459
Email
sales@sibian-chem.com
Country
China
ProdList
1930
Advantage
55
Beijing HuaMeiHuLiBiological Chemical
Tel
010-56205725;010-86181995
Fax
010-65763397
Email
waley188@sohu.com
Country
China
ProdList
12341
Advantage
58
Shanghai Topbiochem Technology Co., Ltd
Tel
021-58170097
Email
sales@topbiochem.com
Country
China
ProdList
9823
Advantage
58
NCE Biomedical Co.,Ltd.
Tel
4000-027-021 |24 hour enquiry :+86-13986109188 |English:+86-15623472865 |Japanese:+81-08033611988
Fax
+86-27-87599188
Email
sales@ncebiomed.com
Country
China
ProdList
1496
Advantage
55
Shanghai T&W Pharmaceutical Co., Ltd.
Tel
+86 21 61551611
Fax
+86 21 50676805
Country
China
ProdList
9914
Advantage
58
Nanjing Norris-Pharm Technology Co., Ltd
Tel
25-66112885
Fax
+86-25-52131256
Email
sales@norris-pharm.com
Country
China
ProdList
9914
Advantage
55
Shanghai Jian Chao Chemical Technology Co., Ltd.
Tel
021-50430803- ;
Fax
qq:2817624287
Email
lyh_antaeus@163.com;1849315414@qq.com
Country
China
ProdList
9641
Advantage
55
Haoyuan Chemexpress Co., Ltd.
Tel
86-21-58998985
Fax
(86) 21-58955996
Email
apisales@chemexpress.com.cn
Country
China
ProdList
7557
Advantage
61
Shanghai Aladdin Bio-Chem Technology Co.,LTD
Tel
400-62063333-1
Fax
021-50323701
Email
market@aladdin-e.com
Country
China
ProdList
24980
Advantage
65
Shanghai Sheepchem Co., Ltd.
Tel
+86 (21) 6715-7650;18918267570
Fax
+86 (21) 6715-7651
Email
sheepchem@163.com
Country
China
ProdList
997
Advantage
60
shanghai cooperpharm co.,LTD .
Tel
+86-021-58975553
Fax
+86-021-58975554
Email
sales@cooperpharm.com
Country
China
ProdList
1210
Advantage
56
China Nobel Chem Co., Limited
Tel
+86(0)21 60484900
Fax
+86(0)21 60484900
Email
sales@nobelchem.com
Country
China
ProdList
765
Advantage
50
Shanghai Yolne Chemical Co., Ltd.
Tel
021-62960152;021-62960152
Fax
021-52212593
Email
sales@yolne.com;sales@yolne.com
Country
China
ProdList
9919
Advantage
55
Chengdu AstaTech Trading Co., Ltd./AstaTech (Chengdu) Pharma. Co., Ltd.
Tel
+86-28-85122536 85324413
Fax
+86-28-85326443
Email
market@astatech.cn
Country
China
ProdList
8043
Advantage
55
Guangzhou Isun Pharmaceutical Co., Ltd
Tel
020-39119399
Fax
020-39119999
Email
isunpharm@qq.com
Country
China
ProdList
4575
Advantage
55
Nanjing Sunlida Biological Technology Co., Ltd.
Tel
025-57798810- ;025-57798810
Fax
025-57019371
Email
sales@sunlidabio.com;sales@sunlidabio.com
Country
China
ProdList
3756
Advantage
55
Shanghai TaoShu Biochemical Technology Co., Ltd.
Tel
021-33632979
Fax
021-33632979
Email
service1@targetmol.com
Country
China
ProdList
7962
Advantage
58
Cato Research Chemicals Inc.
Tel
+1-541-2553640
Fax
+1-541-2553641
Email
info@cato-chem.com
Country
China
ProdList
1958
Advantage
55
Wuhan DKY Technology Co.,Ltd.
Tel
27-81302488- ;27-81302488
Fax
027-81302088
Email
info@dkybpc.com;2851686510@qq.com
Country
China
ProdList
2025
Advantage
58
More
Less

View Lastest Price from Lenalidomide manufacturers

WUHAN CIRCLE POWDER TECHNOLOGY CO.,LTD
Product
Lenalidomide 191732-72-6
Price
US $0.00/KG
Min. Order
100g
Purity
98%+
Supply Ability
100kg
Release date
2020-10-14
Hebei Crovell Biotech Co Ltd
Product
Lenalidomide 191732-72-6
Price
US $10.70/g/Bag
Min. Order
10g
Purity
99%
Supply Ability
10000kg
Release date
2021-07-02
Sinoway Industrial co., ltd.
Product
Lenalidomide 191732-72-6
Price
US $0.00/Kg/Bag
Min. Order
2Kg/Bag
Purity
98% up, USP / BP
Supply Ability
20tons
Release date
2021-07-12

191732-72-6, Lenalidomide Related Search:


  • enalidomide
  • Lenalidomid
  • Revlimid
  • 3-(4-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione,Lenalidomide
  • LenalidoMide(CC-5013,RevliMid)
  • Lenalidomide ,98%
  • 3-(4-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione
  • (3S)-3-(4-Amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione
  • 3-(4-aMino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione
  • (3R)-3-(4-aMino-1-oxo-2,3-dihydro-1H-isoindol-2-yl)piperidine-2,6-dione
  • LenalidoMide (RevliMid)
  • LenalidoMide (CC-5013)
  • LenalidoMide-d5
  • 3-(4-AMino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
  • (3S)-3-(4-amino-1-keto-isoindolin-2-yl)piperidine-2,6-quinone
  • (3S)-3-(4-amino-1-oxo-2-isoindolinyl)piperidine-2,6-dione
  • (3S)-3-(4-amino-1-oxo-isoindolin-2-yl)piperidine-2,6-dione
  • (3S)-3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione
  • enaL
  • idomide
  • CC-5013;CC5013;CC 5013
  • lenalidomide
  • 3-(7-amino-3-oxo-1h-isoindol-2-yl)piperidine-2,6-dione
  • LenalidomideLenalidomide
  • 1-Oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline
  • 3-(4-Amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-2,6-piperidinedione
  • CC-5013
  • Revlimi
  • Lenalidomide(other anti-cancers)
  • To the amine
  • Lenalidomide (This product is only available in Japan.)
  • 3-(4-Amino-1-oxo-2-isoindolinyl)piperidine-2,6-dione
  • 3-(4-amino-1-oxo-2,3-dihydro-1H-isoindol-2-yl)piperidine-2,6-dione
  • Leflunomidum
  • Lenalidomide USP/EP/BP
  • Lenadoamide
  • 99% purity Lenalidomide
  • Lenalidomide (Revlimid, CC5013)
  • 191732-72-6
  • 25926
  • Amines
  • Heterocycles
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
  • Inhibitor
  • CC-5013
  • Inhibitors
  • Molecular Targeted Antineoplastic
  • pharmaceutical intermediate
  • API